that include skin, soft tissues, and device related infections and bacteremia.
www.advancedsciencenews.com www.advhealthmat.de example through FnBP-dependent and -independent pathways have been shown to facilitate S. aureus internalization and survival within human keratinocytes. [2b,7] Once internalized, it has been proposed that this offers protection from humoral immune responses and from the action of several antibiotics. [8] When treating an intracellular infection, a suitable antibiotic should be chosen in order to ensure drug concentration above the minimum inhibitory concentration (MIC) and in the same intracellular location as the targeted microorganism. Depending on their physicochemical properties, antibiotics accumulate in various cell compartments at different concentrations; typically, weak bases tend to accumulate in membranebound acidic compartments, whereas weak acids are excluded from those sites. [9] Specifically, aminoglycosides [10] and macrolides [11] predominantly accumulate in lysosomes, whereas quinolones [8a,12] accumulate in the cytosol. β-lactams [8b] have been shown to accumulate at low level within the cells (predominantly in the cytosol) likely due to their acidic character. Despite the ability of antibiotics to cross cell membrane, their intracellular efficacy can be poor due to: I) low intracellular concentrations below the minimum inhibitory value; II) intracellular environment (e.g., acidic pH) that may affect the antibiotic activity; III) antibiotic accumulation in subcellular compartments that are different from those in which pathogens persist. These limitations could potentially be overcome by utilizing suitable nanocarriers which can enhance the intracellular uptake of antibiotics [13] and facilitate the subcellular targeting. [14] Such nanocarriers can be customized in order to target lysosomes or to escape the endosome, being released into the cytosol. Indeed, carriers made of polycations can provide a "proton sponge effect" [15] or such carriers can be conjugated to membrane-degrading/destabilizing peptides in order to break down the endosome membrane, allowing the "cargo" release into the cytosol. [16] In this respect, a number of strategies have been studied for achieving drug delivery systems that can target specific cellular compartments. [14a,17] Hyaluronan (HA), a generally nontoxic and nonsulfated glycosaminoglycan, is a natural component of human skin and is predominantly employed in the cosmetics industry as a dermal filler. [18] or skincare agent or in viscosupplementation. [18b] A major receptor for HA is cluster of differentiation 44 (CD44), a cell-surface glycoprotein highly expressed on the surface of keratinocytes [19] and activated macrophages. [20] After binding to CD44, HA is taken up by cells and delivered to the lysosomes. [21] CD44 appears to be important in the invasion, survival and persistence of a range of microorganisms within host cells. [22] For example, Group A Streptococcus (GAS) has been shown to attach to epithelial cells through its HA-rich polysaccharide capsule which is reported to mediate attachment to CD44 on pharyngeal and epidermal keratinocytes. [23] Moreover, CD44 was identified as a widely distributed receptor in the epithelial tissues where colonization and infection occur and represented the major cellular receptor for the GAS entry into primary mouse keratinocytes. [22b] CD44 has also been implicated in the cellular internalization of other pathogens such as Mycobacterium tuberculosis in macrophages [22a] and for Shigella spp. in epithelial cells. [22d] Consequently, the application of HA-based nanocarriers may be particularly suitable for targeting intracellular pathogens as: I) a number of host cells (e.g., keratinocytes and macrophages) highly express CD44 and easily internalize HA; II) HA can enter cells through the receptor (CD44) that is also employed by such pathogens; III) like other nanoparticles, HA nanocarriers can be engineered in order to target lysosomes or other cellular compartments [24] ; IV) in the cellular microenvironment the HA nanocarriers may be cleaved by hyaluronidases (HA ase ) that are produced by several bacteria such as Staphylococcus spp. and Streptococcus spp., [25] facilitating the release of the drug in situ. Moreover, the scission of HA can also occur in the presence of host enzymes, acidic pH and free radicals, [26] assuring the drug release within the cells, thus guaranteeing the efficacy of the targeted therapy also against microorganisms that typically do not produce HA ase such as Pseudomonas aeruginosa [27] and Mycobacterium tuberculosis. [28] The data presented herein show the novel application of self-assembling HA-based NHs [29] for enhancing the intracellular uptake of antibiotics into human keratinocytes and targeting to intracellular S. aureus. The efficacy of gentamicin (GM) or levofloxacin (LVF) versus loaded NHs (NH/GM or NH/LVF, respectively) was explored. These two antibiotics were selected as they have different intracellular pathways: GM is a lysosomal drug, [10] while LVF is a cytosolic one. [8a] GM is typically used in topical preparations and can be employed to treat skin infections, while LVF remains among the most active oral antimicrobials.
Results and Discussion

Development and Characterization of NH/GM and NH/LVF
In order to generate NHs, HA carboxyl groups were functionalized with a small hydrophobic molecule, cholesterol (CH). [29] In a previous work, the soft nature, the swelling ability, the spherical shape and size of HA-CH NHs in both dry and aqueous environments (by using atomic force microscopy and transmission electron microscopy techniques) were showed. [30] These nanoparticles evidenced the ability to absorb a high amount of water and to swell in aqueous media, thus showing the typical properties of NHs. [31, 32] As HA chains are chemically modified with a hydrophobic moiety (CH), the resulting amphiphilic polymer is able to self-assemble in aqueous environment and spontaneously forms physically crosslinked tridimensional networks which are characterized by internal hydrophobic domains and hydrophilic outer chains. Depending on the degree of functionalization and on the polymer molecular weight, these aggregates may form regular nanostructures, after suitable treatments such as sonication or autoclaving.
In this respect, it was already shown that autoclaving (121 °C, 20 min) represents a fast and reproducible one-pot method for directly forming sterile and drug-loaded NHs. [33] In this way, both sterile NH/GM and NH/LVF were obtained after autoclaving (Figures 1 and 2 ). Nanosystems were purified from the free antibiotics using a size exclusion chromatography (SEC) column. Drug loading (DL, %), and loading efficiency (LE, %) were studied with an ultraperformance liquid chromatography (UPLC) coupled with a mass-spectrometer (NH/ GM) and with a UV-vis spectrometer (NH/LVF). The amount Mean diameter A) and PDI B) of starting, freeze-thawed and freeze-dried NH/GM. HA-CH/GM mixtures were prepared at several wt ratios (ranging from 1:0.25 to 1:1 of HA-CH and GM, respectively) in 50 × 10 −3 m phosphate buffered saline (PBS, pH = 7.4) and then autoclaved at 121 °C for 20 min. Unloaded GM was discarded by purification through a SEC column. C) ζ-pot of NH/GM samples. D) Release of GM from NHs over 24 h at 37 °C in bidistilled water. Released GM was analyzed though UPLC coupled with mass-spectrometer. All data are expressed as the mean value ± standard deviation. Results were obtained in triplicate (n = 3). were not suitable for the formation of NH/GM as a precipitate was found after the autoclaving process (possible due to the strong electrostatic interactions occurring between GM and HA, which prevent the NHs formation by self-assembling). While, less LVF was loaded into NHs at neutral pH compared to that loaded in double-distilled water (pH = 5). This result can be ascribed to the zwitterionic nature of LVF. Therefore, to maximize the concentration of antibiotics loaded in the NHs a different solvent for each antibiotic was used. As expected, an increase in the amount of loaded GM led to a decrease of the ζ-pot net value of NHs (due to the positively charged GM) compared to that of the unloaded NHs. Indeed, the GM DL% of 40 ± 1%, 35.1 ± 2.8%, and 30.7 ± 2%, w/w led to a ζ-pot change of 49%, 24%, and 20%, respectively, compared to that of free NHs, evidencing a GM concentration-dependent effect. Loaded LVF affected NHs ζ-pot to a lesser extent. Moreover, both NH/GM and NH/LVF stored at −20 °C or freezedried as solid powders, retained their mean diameter and PDI when defrosted and re-hydrated. For preserving the starting NH/GM and NH/LVF properties, it was necessary to add dextrose before freeze-drying ( Figure 1A ,B). The NHs freeze-dried powder ensures the long-term storage of the nanoformulations, as the stability of the aqueous suspensions of NHs and the loaded drugs is rather limited. The antimicrobial activity of NH/LVF freeze-dried powder was already studied against intracellular S. aureus and P. aeruginosa, [27] evidencing the storage method is able to retain the whole activity of the nanoformulation. Furthermore, the NHs freeze-dried powder could be mixed with appropriate materials (e.g., carbopol), at suitable concentrations, in order to obtain formulations for topical administrations. Figures 1 and 2 also show that liquid samples can be frozen, retaining their size and PDI and assuring a longterm storage without the addition of any additive. Among the prepared samples, NH/GM and NH/LVF with the starting 1:1 wt ratio (formulations written in bold in Table 1) showed the best properties and loading efficiency, therefore they were selected for subsequent experiments. To assess the stability of loaded NHs in aqueous environments, drug release studies ( Figures 1D and 2D ) were performed in double-distilled water (pH ≈ 5 similar to that of the human skin). Results showed that only 10%, w/w of loaded GM was released from NHs in 24 h, evidencing the high stability of the nanoformulation. Longer time points were also checked over one week (data not shown), but no changes were observed in the release profile. This behavior can be explained by taking into account that the electrostatic interactions between the negatively charged NHs and the positively charged GM are very strong at low ionic strength. However, some degradation mechanisms should occur in "in vitro" or "in vivo" (e.g., specific enzymes such as HA ase and esterase, acidic pH and free radicals), enhancing the GM release from the NHs. In contrast, 48% w/w of loaded LVF was released over 24 h in the same conditions; this result can be ascribed to weaker interactions within the NHs.
Cell Viability of HaCaT
To determine the effects of antibiotics-loaded NHs on cell viability, HaCaT cells were incubated with NH/GM or NH/LVF or their antibiotic-free controls over 48 h. Both MTT ( Figure 3A ,C) and trypan-blue ( Figure 3B ,D) assays showed that NHs preparations were not toxic to HaCaT, as neither HaCaT metabolism nor vitality was significantly affected by any of the tested concentrations after 48 h ( Figure 3 ).
Antibacterial Activity of NH/GM and NH/LVF against Extracellular and Intracellular S. Aureus
To ensure the NHs encapsulation do not enhance or inhibit antimicrobial activity, the MIC and the minimum bactericidal concentration (MBC) of NHs alongside free GM and LVF, NH/GM and NH/LVF were determined; Figure 4A shows the mean MIC and MBC values. Free NHs did not show any antimicrobial activity and incorporation of GM or LVF into NHs did not affect their antibacterial activity against extracellular S. aureus. The efficacy of the nanoformulations against intracellular S. aureus was then assessed by enumerating viable intracellular bacteria from infected HaCaT treated with NH/ GM, NH/LVF, or their controls, in conditions which did not affect the viability of HaCaT cells, by using the following concentrations: c = 46.8 µg mL −1 (GM) and c = 117 µg mL −1 (NHs) for the NH/GM system and at c = 35.1 µg mL −1 (LVF) and c = 307 µg mL −1 (NHs). Antibiotic concentrations tested were three-folds greater than the MIC/MBC to ensure eradication of viable bacterial cells. After 2 h of incubation, NH/ GM and NH/LVF and their controls were not effective against intracellular S. aureus ( Figure 4B ). After 5 h of incubation both free GM and NH/GM showed significant antimicrobial Table 1 . Drug loading (DL, %) and loading efficiency (LE, %) of NH/GM and NH/LVF prepared at several HA-CH:GM or HA-CH:LVF wt ratios (ranging from 1:1 to 1:0.25). Nanosystems highlighted (bold) were chosen for the biological and microbiological analyses. Experiments were performed in triplicate (n = 3) and results are expressed as the mean value ± standard deviation. 
aureus-infected
HaCaT. Viable cell counts were calculated using three biological replicate count data (each derived from three technical replicate data). All data were log 10 transformed and are expressed as the mean value ± standard deviation. Statistical significance was determined using biological replicate data (n = 3) with Mann-Whitney test by using SPSS 20 Software. p values < 0.05 were considered significant. Asterisk denotes statistically significant differences (*p < 0.05).
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Uptake and Intracellular Fate of HA-CH NHs in HaCaT
Rhodamine B-isothiocyanate (rhod) dye was covalently linked to the hydroxyl groups of NHs and the obtained fluorescent NHs were employed for studying their binding/internalization kinetics and intracellular fate into HaCaT by flow cytometry and fluorescence microscopy. Flow cytometry analysis evidenced that HaCaT incubated for 30 min with rhod-NHs showed a significant increase in fluorescence intensity, indicating a quick binding/uptake of NHs within the cells. HaCaT fluorescence steadily increased over the time and 4 h represented the time point at which the highest signal was detected, followed by a plateau up to 24 h ( Figure 5A ). Moreover, HaCaT cells showed increased fluorescence in a dose-dependent manner with rhodNHs concentrations up to 100 µg mL −1 after 4 h of incubation ( Figure 5B ). ApoTome analysis showed NHs located into vesicle-like structures, those with a diameter of ≈0.3 µm close to the plasma membrane and those in larger vesicles with diameter up to 1.5 µm close to the nucleus, suggesting an intracellular location of NHs (Figure 6 ). Interestingly, Tammi et al. [19a] had a similar outcome using free HA in rat epidermal keratinocytes. [19a] To determine the intracellular fate of NHs and explore the possibility of their colocalization with lysosomes, HaCaT were then incubated up to 24 h with the nanosystem and stained with "Lyso-tracker Green DND-26" (Figure 7) . At 1 h a limited number of NHs was located in lysosomes; however, from 4 to 24 h a strong colocalization occurred (***p value < 0.005) compared to that at 1 h, showing the highest Pearson correlation coefficient value [34] (0.94) at 4 h. NHs in lysosomes were still evident up to 24 h, although colocalization was weaker than that found at 4 h (≈0.7) ( Figure 7) ; no significant differences were found in the time points ranging from 6 to 24 h. Since a previous work showed that LVF predominantly accumulates in the cytosol, it is plausible that NHs are able to change the intracellular fate of LVF (from cytosol to lysosome), delivering the antibiotic to the intracellular location of S. aureus (Figure 8) , thus enhancing its intracellular antimicrobial activity ( Figure 4B ). On the other hand, GM, an antibiotic that predominantly accumulates in lysosomes, showed a significant antibacterial activity without the presence of NHs. These results strongly suggest that therapeutics that are able to accumulate in lysosomes might be more effective against intracellular S. aureus compared with those that accumulate in other cell compartments (e.g., cytosol), evidencing that: I) subcellular targeting could be necessary for eradicating the intracellular pathogen; II) lysosomal nanoparticles (e.g., HA-CH NHs) might be suitable for enhancing the antibacterial activity of such antibiotics against the intracellular S. aureus in human keratinocytes.
Conclusion
We have shown that self-assembled NHs can be loaded with GM or LVF antibiotics by means a fast one-step sterile cycle using an autoclave (121 °C for 20 min). NH/GM and NH/LVF show mean diameters of ≈250 and 350 nm, respectively; both nanoformulations do not affect viability of HaCaT cells at all tested concentrations over 48 h and display the same MIC and MBC values as free antibiotics against extracellular S. aureus. However, intracellularly, the antibacterial activity of LVF was highly enhanced by NHs. As we have demonstrated that NHs colocalize with lysosomes of HaCaT cells and it is known that free LVF predominantly accumulates in the cytosol, these results strongly suggest that NHs may be able to change the intracellular fate of LVF from cytosol to lysosome, thereby targeting intracellular S. aureus. Indeed, GM, an antibiotic that predominantly accumulates in lysosomes, shows significant intracellular activity without the employment of NHs. To conclude, this research demonstrates that lysosomal formulations may be more effective against S. aureus in keratinocytes compared with formulations that accumulate in other cell compartments (e.g., cytosol), opening new avenues for HAbased NHs treatments of persistent S. aureus skin infections.
Experimental Section
Materials: Hyaluronan tetrabutylammonium salt (HA − TBA + , M w = 2.2 × 10 5 ) was purchased from Contipro (Dolní Dobrouč, Czech Republic). CH, 4-bromobutyric acid, N-methyl-2-pyrrolidone (NMP), N-(3-dimethylaminopropyl)-N′-(ethylcarbodimide hydrochloride) (EDC•HCl), GM sulfate, LVF, 4-(dimethylamino)pyridine (DMAP), phosphate buffered saline (PBS) tablets, dextrose, dimethyl sulfoxide (DMSO), American Chemical Society (ACS) grade reagent ≥99,9%, trypsinethylenediaminetetraacetic acid (trypsin-EDTA) solution 10×, formaldehyde solution for molecular biology ≥36.0%, 4′,6-diamidino-2-phenylindole dilactate (DAPI) for nuclei staining, Mowiol 4-88, rhodamine B isothiocyanate, Hanks' balanced salt solution (HBSS) and l-glutamine were purchased from Sigma-Aldrich (Milan, Italy). Dulbecco's Modified Eagle Medium (DMEM 1×) was purchased from Gibco brl life technologies Inc., Grand Island (NY, USA). Lyso-Tracker Green DND-26, Invitrogen Molecular probes were purchased from Thermo Fisher Scientific (Monza, Italy). Triton X-100, albumin from bovine serum, ammonium formate, trypan blue solution were purchased from Biochemica Fluka, Sigma-Aldrich (Milan, Italy). Nitrotetrazolium blue chloride (MTT, CellTiter 96 Non-Radioactive Cell Proliferation Assay) was purchased from Promega (Milan, Italy). Acetonitrile for high performance liquid chromatography (HPLC) and ACS water suitable for UPLC/UHPLC instruments were purchased from VWR (Milan, Italy).
Bacterial Strains: S. aureus NCTC 12973 was obtained from Public Health England, Southampton, UK. Stock cultures were stored at −80 °C using Protect cryobead vials (Technical Service Consultants Ltd, Heywood, UK). Prior to experiments bacterial cultures were revived by transferring cryobead/s onto fresh sterile Mueller-Hinton agar and incubated at 37 °C for 24 h. Dehydrated bacteriological media were obtained from Oxoid (Basingstoke, Hampshire, UK) and reconstituted according to the manufacturer's instructions. Bacterial growth media were sterilized at 121 °C, 15 psi for 15 min prior to use.
General Cell Culture: The human keratinocyte cell line (HaCaT) was spontaneously immortalized from primary keratinocytes [35] and cultured in high glucose DMEM (EuroClone, Milan, Italy) supplemented with 10% (v/v) fetal bovine serum (FBS) and 4 × 10 −3 m glutamine at 37 °C in a humidified atmosphere with 5% CO 2 . Cells were grown to 70-80% semiconfluence, according to each experimental setting and treated with free or loaded antibiotics at several time points and concentrations. All experiments contained untreated cells (PBS) processed in parallel as negative control. HaCaT cells were cultured in complete DMEM for 48 h and then incubated from 1 to 24 h with 100 µg mL −1 rhod-NHs. After specific time points slides were washed with PBS, added again to 1.5 mL of complete DMEM and finally treated with 1 mL of Lyso-Tracker Green (final conc. of 200 × 10 −9 m) for 3 min at 37 °C. Images were immediately recorded on living cells. Pearson's correlation coefficient was calculated using the AxioVision 4.8.2 software (Zeiss) and expressed as the mean value ± standard deviation. Results were obtained from three independent experiments, each derived from eight images. Statistical significance was determined with One-way ANOVA analysis. Differences between groups were determined by a Turkey's multiple comparison test. Asterisks denote statistically significant differences with the incubation time of 1 h (*p < 0.05; **p < 0.01; ***p < 0.005). 
Synthesis of Cholesterol-Br-Butyric Derivative (CH-Br):
CH-Br synthesis was carried out as previously described. [29] Briefly, 500 mg of CH (1.3 × 10 −3 mol) was solubilized in 5 mL of CH 2 Cl 2 and added to 79 mg of DMAP (6.5 × 10 −4 mol); the solution was stirred for 15 min at 25 °C. Meanwhile, 648 mg of 4-bromobutyric acid (3.9 × 10 −3 mol) and 744 mg of EDC•HCl (3.9 × 10 −3 mol) were solubilized in 5 mL of CH 2 Cl 2 ; the two solutions were then mixed and kept at 25 °C with magnetic stirring, overnight. Reaction products were checked with silica gel thin layer chromatography (TLC) (cyclohexane:ethylacetate, 85:15) and then washed once with 50 × 10 −3 m NaOH and HCl and three times with bi-distilled water. The solution was firstly dried with anhydrous Na 2 SO 4 and then with vacuum evaporation. The crude product (powder) was finally purified with a silica column (eluent:cyclohexane:ethylacetate, 98.5:1.5); 310 mg of pure CH-Br were obtained (yield 60%, w/w).
Synthesis of Hyaluronan-Cholesterol Amphiphilic Polymer (HA-CH):
HA-CH synthesis was carried out as previously reported. [29] 200 mg of HA − TBA + (M w = 2.2 × 10 5 ) was added to 10 mL of NMP and the sample was kept at 25 °C for 5 h with magnetic stirring; then, 34.3 mg of CH-Br, previously solubilized in 2 mL of NMP, was added and the reaction was allowed to proceed for 48 h at 38 °C with magnetic stirring. Then, 2 mL of NaCl (saturated solution) was added to the polymer solution and the mixture was left under stirring for 30 min to allow the exchange of the Na + with TBA + ions. The reaction product was precipitated in acetone (4 times the reaction volume), left for 1 h at 4 °C, isolated, re-suspended in bidistilled water and finally dialyzed against water (cellulose membrane tubing, M w cut-off: 1.2-1.4 × 10 4 , Sigma-Aldrich, Darmstadt, Germany) until constant conductivity was reached. Sample was freezedried with a "Modulyo 4K" Edwards High Vacuum instrument, equipped with an Edwards pump, operating at 0.2 atm and at −40 °C, yielding 354 mg of white solid (71% mass recovery). Theoretical degree of functionalization (DF) was 15% (% mol/mol, corresponding to mol of CH per mol of HA repeating unit).
Preparation and Characterization of GM or LVF-Loaded HA-CH Nanohydrogels (NH/GM or NH/LVF):
2 mg of HA-CH was dispersed in 1 mL of Milli-Q water (2 mg mL −1 ) overnight with magnetic stirring at 25 °C. Then 1 mL PBS (pH = 7.4) and 0.1 mL of GM solution (10, 5, or 2.5 mg mL −1 ), or 1 mL Milli-Q water and 0.1 mL of LVF solution (10, 5, or 2.5 mg mL −1 ) (corresponding to 1:1, 1:0.5, and 1:0.25 HA-CH:GM or HA-CH:LVF wt ratio) were added. Samples were then autoclaved for 20 min at 121 °C, leading to NH/GM or NH/LVF formation. NH/GM or NH/LVF were purified from the free antibiotics through SEC. SEC was performed using Econo-Pac chromatography columns (Bio-Rad, Segrate, Italy) packed with Bio-Gel P-10 (polyacrylamide with an exclusion limit range of 1.5-20 × 10 3 , Bio-Rad, Segrate, Italy). 1 mL of NH/GM or NH/ LVF mixtures was loaded into SEC and eluted with 10 mL PBS or water, respectively, at 25 °C and atmospheric pressure.
Dynamic Light Scattering (DLS):
Hydrodynamic diameter (Z-average size), size distribution, PDI, and ζ-potential of NH/GM or NH/LVF were measured by DLS at 25 °C by using a Zetasizer Nano ZS instrument (Model ZEN3690, Malvern Instruments) equipped with a solid state HeNe laser (λ = 633 nm) at a scattering angle of 173°. Size measurement data were analyzed by using the general purpose algorithm. The electrophoretic mobility of the samples was converted in ζ-potential by using the Smoluchowski equation. Hydrodynamic diameter and PDI of freeze-thawed or freeze-dried NH/GM or NH/LVF were also studied; empty NHs were prepared as controls. Each experiment was performed in triplicate (n = 3).
Quantification of Entrapped GM into NHs: UPLC Coupled to Mass Spectrometry (UPLC-MS) Analysis:
The amount of GM entrapped into NHs was checked with a Waters Acquity H-Class UPLC-MS (Waters, Milford, MA, USA), equipped with a quaternary solvent manager, a sample manager with flow through needle system and a single-quadrupole mass detector with electrospray ionization source (ACQUITY QDa). Free GM solutions were diluted with water, filtered with 0.22 µm regenerated cellulose membrane filters (Sartorius Italy s.r.l., Monza, Italy) and injected into a Waters BEH Shield C18 column (50 mm × 2.1 mm i.d., 1.7 µm particle size). Samples were eluted using an isocratic 10 × 10 −3 m HCOONH 4 mobile phase (pH = 3) at a flow rate of 0.5 mL min −1 and column temperature of 25 °C. Mass spectrometry detection was performed in positive electrospray ionization mode, using nitrogen as nebulizer gas. Three m/z values (478, 464, and 450) corresponding to the three [M+H] + GM chemical species were monitored in single ion recognition mode. Capillary and cone voltage were set to 0.8 kV and 15 V; ion source and probe temperatures were adjusted to 120 and 600 °C. A GM calibration curve was calculated at the concentration range of 7.5-125 µg mL −1 (R 2 = 0.98, n = 3).
Quantification of Entrapped LVF into NHs: UV-Vis Spectrometry Analysis: The amount of LVF entrapped into NHs was assessed by using a Perkin-Elmer double beam "Lambda 3A" model. Analyses were performed at 25 °C, using 1 mm quartz cuvettes (Hellma Analytics, Milan, Italy). LVF water solutions were detected at 286 nm. A LVF calibration curve was built at the concentration range of 16-200 µg mL −1 (R 2 = 0.999, n = 5). The amount of entrapped GM or LVF was calculated by subtracting the amount of unloaded GM or LVF from the starting total amount of drugs. Each experiment was performed in triplicate (n = 3).
Drug loading (DL%) and loading efficiency (LE%) of both GM and LVF were calculated using the following Equations (1) and (2) DL% weight of loaded drug weight of total drug 100 = ×
LE% weight of loaded drug weight of polymer 100
In Vitro Release Studies of GM or LVF from NHs: 1 mL of purified NH/ GM or NH/LVF (1:1 starting wt ratio) was put into a membrane tube (M w cut-off 1.2-1.4 × 10 4 ) and dialysis was performed against 15 mL bidistilled water for 24 h, at 37 °C; at specific time points 3 mL solution was taken off and replaced with 3 mL of bidistilled water. Samples were then injected into UPLC-MS or analyzed with UV-vis spectrometer for quantifying the amount of released GM or LVF from NHs, respectively. Each experiment was performed in triplicate (n = 3).
Cell Viability Assays: HaCaT viability was tested in parallel with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide metabolic assay (MTT assay) and trypan blue exclusion method, by counting both dead and living cells.
Cell Viability Assays: (A) MTT Test: 100 µL HaCaT (5000 cells per well in complete DMEM) was seeded in a 96 well plate (Falcon Polystyrene Microplates, Thermo Fisher Scientific, Monza, Italy) and incubated for 24 h. Cell monolayers were then added to 25 µL of samples (free NHs, GM or LVF, NH/GM or NH/LVF in PBS pH = 7.4) at specific final NHs concentrations (ranging from 18 to 500 and 37 to 1000 µg mL −1 for NH/ GM and NH/LVF, respectively, df: 1:3) and incubated for 24 and 48 h. As negative control, cells received 25 µL PBS. Then, medium was removed, cells were gently washed with PBS and 100 µL complete DMEM was added. 20 µL MTT solution (Promega, Italy, Milan) was added and HaCaT were incubated for 2 h. Supernatants were gently removed and formazan crystals were solubilized with 100 µL DMSO. Absorbance was checked at 570 nm with a reference at 690 nm, using an Appliskan microplate reader (Thermo Scientific, Vantaa, Finland). Each experiment was performed on 16 wells (n = 3). Results were processed using SkanIt 2.3 Software.
Cell Viability Assays: (B) Trypan Blue Exclusion Method: 1.5 mL HaCaT (167 000 cells per well in completed DMEM) were seeded in a 6 well plate and incubated for 24 h. 0.375 mL of free NHs or NH/GM or NH/ LVF in PBS at the final NHs concentration of 500 or 1000 µg mL −1 (NH/ GM or NH/LVF, respectively) were then added to the cells, which were incubated for 24 and 48 h. As negative control, cells received 0.375 mL PBS. Subsequently, medium (1.875 mL) was taken off and stored into eppendorf tubes (Primo boil-proof microcentrifuge tubes, EuroClone spA, Milan, Italy); then, wells were gently washed with 1 mL PBS and 0.6 mL 0.5% trypsin were added. Cells were allowed to detach for 10 min at 37 °C and then added to the previously removed 1. 875 (Carl Zeiss Microimaging GmbH, Gottingen, Germany) in a Neubauer chamber. Each experiment was performed in triplicate (n = 3).
Determination of MICs and MBCs:
The MIC and MBC were determined for axenic planktonic populations of S. aureus using the microdilution method. [36] Briefly, 100 µL double strength Mueller-Hinton broth was dispensed in wells of the first column of a flat bottom 96 well microtiter plate. Stationary phase cultures of S. aureus grown in Mueller-Hinton broth were adjusted in fresh sterile Mueller-Hinton broth to give a cell density of ≈2 × 10 6 CFU mL −1 . Within 30 min of preparation inocula were dispensed (100 µL) into the remaining wells the 96 well plate. Stock solutions of free GM, LVF, NHs, or NH/GM or NH/LVF were prepared in sterile PBS and dispensed (100 µL) into the first column of the microtiter plate. Doubling dilutions of samples were then undertaken across the plate (100 µL). Plates were incubated at 37 °C for 24 h. The MIC endpoint was determined as the lowest concentration of antimicrobial that prevented visible growth. To determine the MBC, aliquots (10 µL) from wells exhibiting no turbidity were spot plated onto sterile Mueller-Hinton agar. After incubation at 37 °C, the MBC endpoint was determined as the lowest concentration that resulted in no visual growth of colonies after 24 h of incubation. Each experiment was performed in triplicate (n = 3).
Cell Infection and Assessment of Intracellular Activity of NH/GM or NH/ LVF:
To assess the efficacy of free or loaded GM or LVF on intracellular bacteria, HaCaT cell monolayers were grown to 70-80% semiconfluence by seeding 1.5 × 10 5 cells in 1 mL of complete DMEM (2 × 10 −3 m glutamine) in 24 well plates and incubating for 18 h. Mid-log phase cultures of S. aureus were washed twice with sterile PBS and culture densities adjusted in sterile, FCS free DMEM to give a cell density of ≈100 CFU per cell (100 multiplicity of infection, MOI). Growth medium was removed and HaCaT cells were washed with sterile PBS and FCS free medium was added to each well. Aliquots of adjusted bacterial cultures were added to cells and plates were incubated for a further 3 h. In order to remove any extracellular bacteria, cell culture media were then removed from wells and 1 mL fresh serum free media containing X2 MIC gentamicin added. Plates were further incubated for 1 h. Medium was removed and HaCaT cells were washed twice with sterile PBS. Free GM or LVF and their nanoformulations were reconstituted in sterile PBS and diluted to the desired concentration in fresh serum free DMEM in order to have 3× MIC value (final concentration of drugs in the well). 1 mL aliquots of treatments were then added to cells and plates were incubated for either 2 or 5 h. After incubation, cells were washed twice with PBS and lysed with 0.025% Triton X for 10 min. To enumerate viable bacteria, lysates were harvested and serially diluted in sterile PBS and inoculated onto Mueller-Hinton agar. Agar plates were incubated for >16 h and viable counts performed. All experiments contained noninfected cell monolayers processed in parallel as a sterile control and infected cell monolayers processed with serum free media in the absence of any test treatment as a positive control. Each experiment was performed in triplicate (n = 3).
Synthesis of Fluorescent NHs (rhod-NHs): 1.5 mg mL −1 HA-CH polymer in bi-distilled water was left with magnetic stirring overnight at 25 °C. The sample was placed in an autoclave (121 °C for 20 min) where NHs were allowed to form. Rhodamine B-isothiocyanate (rhod) was previously solubilized in DMSO at a concentration of 9 mg mL −1 and then added to NHs suspension (8 µL for 1 mg of polymer, corresponding to a DF of 6.3%; % mol mol −1 ). The reaction mixture was left for 5 h at 25 °C in the dark, following which it was dialyzed against water until constant conductivity was reached and then freeze-dried. The final DF% was assessed through UV-vis analysis: sample was solubilized in DMSO and checked at 550 nm at 25 °C. A rhod calibration curve was built at the concentration range of 8.5-125 µg mL −1 in DMSO. DF corresponded to 1.3% (mol of rhod per mol of HA-CH repeating unit).
Flow Cytometry Analysis: Cell binding/uptake kinetics of fluorescent NHs was studied with a BD Accuri C6, BD 254 Bioscences (Erembodegem, Belgium) flow cytometer equipped with a 488 nm excitation laser and a 585/40 nm bandpass filter (FL2 channel). For each sample 50 000 events were collected. 1 mL HaCaT cell suspension (67 000 cells per well in complete DMEM) was seeded in 12 well plates and incubated for 48 h. Cells were washed three times with PBS, 1.5 mL of complete DMEM added and treated with 0.25 mL of 0.5 mg mL −1 rhod-NHs in PBS (corresponding to a final concentration of 0.10 mg mL −1 ) at specific time points, over 24 h. Medium was removed, cells were washed three times with PBS, allowed to detach with 0.25 mL trypsin and finally added to 0.75 mL complete DMEM. Cell suspensions were centrifuged in eppendorf tubes for 8 min at 1200 rpm at 4 °C. Supernatants were removed and pellets were washed with 1 mL HBSS solution and centrifuged again. Pellets were resuspended in 0.5 mL HBSS and red fluorescence (rhod) was detected with a flow cytometer. HaCaT cells were also treated with 0.25 mL of rhod-NHs (final concentrations 10, 50, 100, 500 µg mL −1 ) at a fixed time point (4 h) by following the same procedure and then analyzed with a flow cytometer. As a negative control, cells received 0.25 mL PBS. Results were expressed as median fluorescence intensity (n = 3). A dot plot was built by plotting forward scatter (FSC-H) versus side scatter (SSC-H) and the gate was constructed excluding cell debris. Each experiment was performed in triplicate (n = 3).
Cell Imaging: ApoTome Microscope: Immunofluorescence signal of fluorescent NHs was analyzed by recording stained images using an Axio Observer Z1 inverted microscope, equipped with an ApoTome.2 System (Carl Zeiss Inc., Ober Kochen, Germany). The ApoTome system provides an optical section of fluorescent samples, calculated from three images with different grid positions without time lag. Digital images were acquired with the AxioCam MRm high resolution digital camera (Zeiss) and processed with the AxioVision 4.8.2 software (Zeiss). ApoTome optical sectioning images of fluorescent NHs were recorded under 40×/0.75 objective (Zeiss). Pearson's correlation coefficient [32] was used to quantify the degree of colocalization between fluorescent NHs and Lyso-Tracker Green DND-26 staining in a series of 0.5 nm sequential sections, under an immersion oil 63×/1.25 objective (Zeiss). Pearson's correlation coefficient was calculated using the AxioVision 4.8.2 software (Zeiss), analyzing a minimum of 40 cells randomly taken from each slide from three independent experiments. Images were obtained from the 2D reconstruction of selected serial optical sections.
Cellular Uptake Micrographs: 1.5 mL HaCaT cells (167 000 cells per well in complete DMEM) were seeded on microscope slides (Prestige micro cover glass 22 mm × 22 mm, Syntesys Disposable Labware, Padova, Italy) in a 6 well plate and allowed to adhere for 48 h. Then, cells were washed three times with PBS, 1.5 mL of complete DMEM added and incubated with 0.375 mL of 0.5 mg mL −1 rhod-NHs in PBS (corresponding to a final concentration of 0.1 mg mL −1 ) or free rhod previously solubilized in DMSO (final concentration of 7.2 µg mL −1 ). After 4 h, medium was removed and cells were washed three times with PBS. Cells were fixed with 2% (v/v) formaldehyde (2 mL, 10 min), washed three times with PBS, and incubated with Triton X-100 (0.1%, v/v, 2 mL, 5 min). Cells were washed three times with PBS and nuclei were stained with DAPI reagent (1 µg mL −1 , 1 mL for 1 min). Finally, cells were washed again and 8 µL Mowiol was added; slides were allowed to dry and fix overnight at 25 °C on StarFrost microscope slides (Braunschweig, Germany). Samples were then analyzed with the ApoTome microscope.
Lysosomal Colocalization in Living Cells: 1.5 mL HaCaT (167 000 cells per well in complete DMEM) were seeded on microscope slides in a 6 well plate and allowed to adhere for 48 h. Cells were washed three times with PBS, 1.5 mL of complete DMEM added and incubated with 0.375 mL of 0.5 mg mL −1 rhod-NHs (corresponding to a final concentration of 0.1 mg mL −1 ). After several time points (from 0.5 to 24 h) slides were washed three times with PBS, 1.5 mL of complete DMEM added and finally incubated with 1 mL of Lyso-Tracker Green DND-26 staining (final concentration of 200 × 10 −9 m) for 3 min at 37 °C. Images were immediately recorded on living cells with the ApoTome microscope. Results were obtained from three independent experiments, each derived from eight images. biological replicate count data (each derived from three technical replicate data). All data were log10 transformed and are expressed as the mean value ± standard deviation. Statistical significance was determined using biological replicate data (n = 3) with Mann-Whitney test by using SPSS 20 Software. p values < 0.05 were considered significant. Asterisk denote statistically significant differences (*p < 0.05). Statistical Analysis: Cell Viability and Cell Count Assays: Viable HaCaT (MTT and trypan blue) were calculated using three biological replicates (each derived from 16 wells). Cell viability and cell growth were normalized to the negative control (untreated cells that received PBS), while the cell death was normalized to the total amount of cells. All data were expressed as the mean value ± standard deviation. Statistical significance was determined using 16 wells (n = 3) with One-way ANOVA analysis in Prism (GraphPad 5.0 Software, Inc., La Jolla, CA, USA). Differences between groups were determined by a Turkey's multiple comparison test. Asterisks denote statistically significant differences (*p < 0.05; **p < 0.01; ***p < 0.005).
Colocalization Experiments: Pearson's correlation coefficient was used to quantify the degree of colocalization between fluorescent NHs and Lyso-Tracker Green DND-26 staining, which was calculated using the AxioVision 4.8.2 software (Zeiss) and expressed as the mean value ± standard deviation. Results were obtained from three independent experiments, each derived from eight images. Statistical significance was determined using one-way ANOVA analysis. 
